BioByte 121: biology as the next software platform, language development in children, a massive Perturb-seq dataset, and morning coffee as a cancer treatment

BioByte 120: FutureHouse launches ether0, introducing Origene as a virtual disease biologist, newly released Boltz-2 targets binding affinity, and combating negativity besieging biotech

BioByte 119: e-tattoos that measure mental workload, introducing Biomni, FrankenROCS identifies drug candidates for Covid, and evolutionary watermarking to trace protein structures with FoldMark

BioByte 118: terraforming Mars, broadly neutralizing antibodies targeting HIV, bioprinting inside the body, and AI modeled on neurons for continuous thought